PeptidePros
All Guides

Dosing & Reconstitution

How to Reconstitute Peptides

A practical guide to reconstitution math, handling basics, and the mistakes that create contamination or dosing problems.

intermediateDosing & ReconstitutionUpdated Apr 2026
Inte.
Level
3
Sections
2
FAQs
Apr 2026
Updated

Decision path

Use the guide as a safety framework.

Learn the framework first, then check risk, vendor documentation, and personal fit before choosing a compound path.

Dosing & Reconstitution
  1. 01

    Learn the framework

  2. 02

    Check risk

  3. 03

    Take the quiz

  4. 04

    Compare vendors

Guide next step

Use the guide before choosing a compound.

Take the quiz after this guide so the next page reflects your goal, risk tolerance, and monitoring comfort.

Why this matters

Reconstitution errors create bad dosing, waste product, and contamination risk.

A lot of people memorize syringe numbers without understanding the math.

Good handling habits matter as much as the final concentration.

Key takeaways

Takeaway 1

Always understand the concentration you are creating, not just the amount of fluid you added.

Takeaway 2

Gentle handling matters. Swirl instead of shaking unless a manufacturer explicitly says otherwise.

Takeaway 3

A clean vial, clean stopper, and clean workspace are part of the process, not optional extras.

Takeaway 4

If the product page does not clearly describe the form and amount in the vial, your math starts on bad footing.

Guide protocol path

Use this framework before turning research into a protocol.

  1. 1

    Baseline

    Clarify goal, labs, contraindications, and sport/testing status.

  2. 2

    Choose

    Pick one primary compound path before stacking extras.

  3. 3

    Source

    Check vendor documentation, COA fit, and route constraints.

  4. 4

    Monitor

    Track outcomes, adverse effects, and stop conditions.

  5. 5

    Reassess

    Review whether the protocol still fits after the first cycle.

The only math you really need

Reconstitution math is concentration math. Divide the amount of peptide in the vial by the amount of diluent you add. That gives you the amount of compound per mL.

Once you know concentration, you can convert to whatever measurement system you use downstream. The common mistake is memorizing syringe-unit examples without understanding the concentration underneath them.

The exact amount per draw depends on the concentration you create.
Example vialDiluent addedResulting concentration
5 mg vial1 mL5 mg/mL
5 mg vial2 mL2.5 mg/mL
10 mg vial2 mL5 mg/mL

Preparation checklist

Confirm the peptide amount and product form before opening anything.

Use a clean workspace and wipe vial stoppers before access.

Add diluent slowly against the inside wall of the vial when possible.

Swirl gently and let the powder dissolve. Avoid aggressive shaking.

Label the vial with date and concentration so the math is not repeated from memory later.

Mistakes that matter

Using the wrong vial strength because two similar products looked the same.
Forgetting that a blend product changes the math and the interpretation.
Treating a cloudy or unusual-looking solution as normal without checking vendor guidance.
Using poor storage after reconstitution and assuming the concentration is the only variable that matters.

This guide is educational, not dosing advice

The purpose here is to explain concentration and handling logic so users can understand product preparation, not to provide individualized medical direction.

Frequently asked questions

Why does everyone talk in syringe units instead of mg per mL?

Because many people learn from examples, not principles. Concentration is the more durable concept because it survives changes in vial size and diluent volume.

Should every peptide be handled the same way?

No. Reconstitution basics are similar, but stability, storage, and agitation sensitivity can differ by compound and formulation.

Sources and review notes

  1. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15

    Used for FDA compounding-risk context and peptide safety flags.

  2. The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15

    Used for athlete-facing WADA risk and peptide-class restrictions.

  3. Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15

    Used for broad peptide-therapeutics background and evidence framing.

Use these guides to build confidence first — then compare compounds, review vendor documentation, and take the quiz when you're ready for a plan.